Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Celldex Therapeutics, Inc. CLDX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$24.00
-28%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Celldex Therapeutics, Inc. (CLDX), dont 38 achats et 9 ventes. Le total des achats d'initiés s'élève à $62.28M et le total des ventes d'initiés à $3.21M.

Les initiés notables ayant une activité récente comprennent Martin Samuel Bates, Pepin Ronald, Jimenez Freddy A.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — CLDX

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-01-02 Martin Samuel Bates SVP and CFO Exercice d'Options 4,817 $10.38 $50K 32,942
2025-12-15 Pepin Ronald Sr. VP & Cbo Exercice d'Options (Vente) 11,000 $2.78 $30.58K -
2025-12-04 Jimenez Freddy A. SVP & General Counsel Vente Informative 4,166 $29.10 $121.21K 30,796
2025-11-13 Wright Richard M. Other: Former Officer Exercice d'Options (Vente) 26,672 $10.38 $276.86K -
2025-11-10 Lawver Teri L Officer Inconnu - - - -
2025-11-10 Lawver Teri L SVP & Chief Commercial Officer Attribution de RSU 100,000 $22.67 $2.27M 100,000
2025-08-13 Jimenez Freddy A. SVP & General Counsel Vente Informative 430 $25.42 $10.93K 34,962
2025-06-05 Torres Denice Director Inconnu - - - -
2025-06-05 Penner Harry Jr Director Attribution de RSU 16,500 $19.53 $322.25K 16,500
2025-06-05 Marino James J Director Attribution de RSU 16,500 $19.53 $322.25K 16,500
2025-06-05 Pepin Ronald Sr. VP & Cbo Attribution de RSU 20,000 $19.53 $390.6K 20,000
2025-06-05 Conrad Herbert J Director Attribution de RSU 16,500 $19.53 $322.25K 16,500
2025-06-05 Keler Tibor Executive VP & CSO Attribution de RSU 93,000 $19.53 $1.82M 93,000
2025-06-05 Marucci Anthony S President & CEO Attribution de RSU 300,000 $19.53 $5.86M 300,000
2025-06-05 Brownlie Keith L Director Attribution de RSU 16,500 $19.53 $322.25K 16,500
2025-06-05 Cohen Cheryl Director Attribution de RSU 16,500 $19.53 $322.25K 16,500
2025-06-05 Neil Garry Arthur Director Attribution de RSU 16,500 $19.53 $322.25K 16,500
2025-06-05 Young Diane C. SVP, Chief Medical Officer Attribution de RSU 72,000 $19.53 $1.41M 72,000
2025-06-05 Crowley Elizabeth Sr. VP & Cpdo Attribution de RSU 85,000 $19.53 $1.66M 85,000
2025-06-05 Jain Rita Director Attribution de RSU 16,500 $19.53 $322.25K 16,500
2025-06-05 Martin Samuel Bates SVP and CFO Attribution de RSU 81,000 $19.53 $1.58M 81,000
2025-06-05 Cavanaugh Sarah SVP of Corp Affairs & Admin. Attribution de RSU 78,000 $19.53 $1.52M 78,000
2025-06-05 Heath-chiozzi Margo SVP of Regulatory Affairs Attribution de RSU 82,000 $19.53 $1.6M 82,000
2025-06-05 Torres Denice Director Attribution de RSU 33,000 $19.53 $644.49K 33,000
2025-06-05 Jimenez Freddy A. SVP & General Counsel Attribution de RSU 75,000 $19.53 $1.46M 75,000
2024-11-18 Marino James J Director Don (Donné) 10,500 - - 2,204
2024-11-11 Marucci Anthony S President & CEO Achat Informatif 11,500 $26.82 $308.43K 40,284
2024-06-14 Crowley Elizabeth Sr. VP & Cpdo Vente Informative 30,000 $34.87 $1.05M 9,074
2024-06-14 Martin Samuel Bates SVP and CFO Exercice d'Options (Vente) 3,201 $9.02 $28.86K -
2024-06-13 Penner Harry Jr Director Attribution de RSU 16,500 $36.43 $601.1K 16,500
2024-06-13 Marino James J Director Attribution de RSU 16,500 $36.43 $601.1K 16,500
2024-06-13 Pepin Ronald Sr. VP & Cbo Attribution de RSU 20,000 $36.43 $728.6K 20,000
2024-06-13 Conrad Herbert J Director Attribution de RSU 16,500 $36.43 $601.1K 16,500
2024-06-13 Shoos Karen L. Director Attribution de RSU 16,500 $36.43 $601.1K 16,500
2024-06-13 Keler Tibor Executive VP & CSO Attribution de RSU 93,000 $36.43 $3.39M 93,000
2024-06-13 Marucci Anthony S President & CEO Attribution de RSU 300,000 $36.43 $10.93M 300,000
2024-06-13 Brownlie Keith L Director Attribution de RSU 16,500 $36.43 $601.1K 16,500
2024-06-13 Cohen Cheryl Director Attribution de RSU 16,500 $36.43 $601.1K 16,500
2024-06-13 Neil Garry Arthur Director Attribution de RSU 16,500 $36.43 $601.1K 16,500
2024-06-13 Wright Richard M. Sr. VP & Cco Attribution de RSU 65,000 $36.43 $2.37M 65,000
2024-06-13 Young Diane C. SVP, Chief Medical Officer Attribution de RSU 72,000 $36.43 $2.62M 72,000
2024-06-13 Crowley Elizabeth Sr. VP & Cpdo Attribution de RSU 85,000 $36.43 $3.1M 85,000
2024-06-13 Jain Rita Director Attribution de RSU 16,500 $36.43 $601.1K 16,500
2024-06-13 Martin Samuel Bates SVP and CFO Attribution de RSU 81,000 $36.43 $2.95M 81,000
2024-06-13 Cavanaugh Sarah SVP of Corp Affairs & Admin. Attribution de RSU 78,000 $36.43 $2.84M 78,000
2024-06-13 Heath-chiozzi Margo SVP of Regulatory Affairs Attribution de RSU 82,000 $36.43 $2.99M 82,000
2024-06-13 Jimenez Freddy A. SVP & General Counsel Attribution de RSU 75,000 $36.43 $2.73M 75,000
2024-06-11 Young Diane C. SVP, Chief Medical Officer Exercice d'Options (Vente) 15,000 $2.71 $40.65K -
2024-06-07 Young Diane C. SVP, Chief Medical Officer Vente Informative 45,000 $35.26 $1.59M 2,115
2024-06-07 Crowley Elizabeth Sr. VP & Cpdo Exercice d'Options (Vente) 7,500 $9.02 $67.62K -
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message